How a Failed Clinical Trial Led to a Breakthrough Finding for Cancer Immunotherapy
A recent failed clinical trial by British and American researchers resulted in a breakthrough in cancer immunotherapy research. The team of researchers from the University of Liverpool and the La Jolla Institute for Immunology in California believe their findings...
Could This Pancreatic Cancer Study Lead to a New Diagnostic Tool?
A recent study partly funded by Worldwide Cancer Research has uncovered evidence that scientists may be able to detect pancreatic cancer through stool samples. Researchers in this study discovered 27 microbial species in stool samples that could indicate the most...
Could Honeybee Venom Be Used to Treat Cancer?
In the world of oncology, researchers are constantly searching for new treatment methods with the potential to improve patient outcomes. A recent study may have found an example in an unexpected place: honeybee venom. Australian researchers at the Harry Perkins...
Can Remote Technology Increase Participation in Cancer Clinical Trials?
A study recently published in the Journal of the American Medical Association (JAMA) suggests that remote technologies could potentially lead to an increase in volunteers for cancer clinical trials. Researchers surveyed 1,183 cancer patients who had been diagnosed or...
Could Certain Cancer Patients Skip Treatment after Surgery?
Two recent cancer studies have shown that some cancer patients may be able to safely skip radiation or chemotherapy following surgery. The first study used a blood test to evaluate which colon cancer patients could safely forgo post-surgery treatment, while the other...
Male Sex Hormones as a New Target for Cancer Immunotherapy?
Statistically, men with cancer have worse prognoses and outcomes compared to women. This discrepancy has been the subject of extensive study over the past few decades, but the oncology community is still working toward understanding the difference. However, a study...
Cancer-Killing Virus Tested on First Human Patient in Clinical Trial
In a recent clinical trial, an experimental cancer-killing virus was tested on a human patient for the first time. Known by the brand name Vaxinia (CF33-hNIS), the tested drug is a type of oncolytic virus therapy. This genetically modified virus is designed to...
Could Popular HIV Drug Lamivudine Be Used to Treat Metastatic Cancers?
A drug commonly used to treat HIV patients may be a viable treatment for metastatic cancers, according to findings from a trial recently published in the journal Cancer Discovery. While the study focused on patients with fourth-line metastatic colorectal cancer, the...
Can Artificial Intelligence Diagnose Cancer More Accurately Than Radiologists?
Oncology researchers have been exploring whether artificial intelligence can be used to detect cancer faster or more accurately than radiologists. A promising new breast cancer study by German researchers suggests that AI could detect breast cancer in ways that...
Spanish Cancer Study: Could These Findings Improve Treatment of Metastatic Cancers?
Researchers at the Spanish National Cancer Research Centre (CNIO) have made a pair of discoveries that could potentially improve the treatment of metastatic brain cancers. In a study led by Dr. Manuel Valiente, the team of researchers found a new biomarker that could...
